191 related articles for article (PubMed ID: 31178864)
1. Excessive miR-152-3p Results in Increased BAFF Expression in SLE B-Cells by Inhibiting the KLF5 Expression.
Luo S; Ding S; Liao J; Zhang P; Liu Y; Zhao M; Lu Q
Front Immunol; 2019; 10():1127. PubMed ID: 31178864
[TBL] [Abstract][Full Text] [Related]
2. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
[TBL] [Abstract][Full Text] [Related]
3. Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-α/BAFF axis pathway by miR-155.
Aboelenein HR; Hamza MT; Marzouk H; Youness RA; Rahmoon M; Salah S; Abdelaziz AI
Growth Factors; 2017 Jun; 35(2-3):49-60. PubMed ID: 28683581
[TBL] [Abstract][Full Text] [Related]
4. BCL-6 suppresses miR-142-3p/5p expression in SLE CD4
Ding S; Zhang Q; Luo S; Gao L; Huang J; Lu J; Chen J; Zeng Q; Guo A; Zeng J; Lu Q
Cell Mol Immunol; 2020 May; 17(5):474-482. PubMed ID: 31431691
[TBL] [Abstract][Full Text] [Related]
5. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
6. Targeting of EIF4EBP1 by miR-99a-3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression.
Yang M; Yang B; Deng D
J Cell Mol Med; 2021 Nov; 25(21):10291-10305. PubMed ID: 34668631
[TBL] [Abstract][Full Text] [Related]
7. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
[TBL] [Abstract][Full Text] [Related]
8. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
9. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
10. B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.
Zayed RA; Sheba HF; Abo Elazaem MA; Elsaadany ZA; Elmessery LO; Mahmoud JA; Abdel Rahman DR; Abdou FR
Ann Clin Lab Sci; 2013; 43(3):289-94. PubMed ID: 23884224
[TBL] [Abstract][Full Text] [Related]
11. Expression of BAFF and BR3 in patients with systemic lupus erythematosus.
Duan JH; Jiang Y; Mu H; Tang ZQ
Braz J Med Biol Res; 2016 Mar; 49(3):. PubMed ID: 26840704
[TBL] [Abstract][Full Text] [Related]
12. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.
Jacob N; Guo S; Mathian A; Koss MN; Gindea S; Putterman C; Jacob CO; Stohl W
J Immunol; 2011 Apr; 186(8):4984-93. PubMed ID: 21383240
[TBL] [Abstract][Full Text] [Related]
13. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE.
Wang Y; Liang J; Qin H; Ge Y; Du J; Lin J; Zhu X; Wang J; Xu J
Arthritis Res Ther; 2016 Nov; 18(1):263. PubMed ID: 27852285
[TBL] [Abstract][Full Text] [Related]
15. Gender differences of B cell signature related to estrogen-induced IFI44L/BAFF in systemic lupus erythematosus.
Fan H; Zhao G; Ren D; Liu F; Dong G; Hou Y
Immunol Lett; 2017 Jan; 181():71-78. PubMed ID: 27923569
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus.
Tao B; Xiang W; Li X; He C; Chen L; Xia X; Peng T; Peng L; Yang X; Zhong C
Inflamm Res; 2021 Mar; 70(3):285-296. PubMed ID: 33507312
[TBL] [Abstract][Full Text] [Related]
17. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.
Lin Z; Dan-Rong Y; Xiao-Qing T; Hao W; Hong-Lian G; Xian-Tao K; Ren-Qian Z; Jiyu L
J Clin Lab Anal; 2007; 21(3):183-7. PubMed ID: 17506477
[TBL] [Abstract][Full Text] [Related]
18. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.
Vincent FB; Morand EF; Mackay F
Immunol Cell Biol; 2012 Mar; 90(3):293-303. PubMed ID: 22231653
[TBL] [Abstract][Full Text] [Related]
19. [Effect of miR-202 on the growth of multiple myeloma cells via regulating B cell-activating factor and the underlying mechanism].
Yu JJ; Shen XJ; Wang XD; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):886-91. PubMed ID: 24506956
[TBL] [Abstract][Full Text] [Related]
20. Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity.
Stohl W; Jacob N; Guo S; Morel L
Arthritis Rheum; 2010 Aug; 62(8):2432-42. PubMed ID: 20506216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
